Shadman, M., Li, H., Rimsza, L., Leonard, J., Kaminski, M., Braziel, R., … Press, O. (2018). Continued Excellent Outcomes in Previously Untreated Patients With Follicular Lymphoma After Treatment With CHOP Plus Rituximab or CHOP Plus ¹³¹I-Tositumomab: Long-Term Follow-Up of Phase III Randomized Study SWOG-S0016. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, JCO2017745083. https://doi.org/10.1200/JCO.2017.74.5083 (Original work published 2018)

Ramalingam, S., Pérol, M., Reck, M., Kowalyszyn, R., Gautschi, O., Kimmich, M., … Garon, E. (2017). Efficacy and Safety of Ramucirumab With Docetaxel Versus Placebo With Docetaxel as Second-Line Treatment of Advanced Non-Small-Cell Lung Cancer: A Subgroup Analysis According to Patient Age in the REVEL Trial. Clinical Lung Cancer. https://doi.org/10.1016/j.cllc.2017.12.011 (Original work published 2017)